We are live on ! Find out more
EPP icon

iShares MSCI Pacific ex Japan ETF

Positive
Neutral
Negative
Sentiment 3-Months
Positive 16.7%
Neutral 55.6%
Negative 27.8%

Negative
WSJ
12 days ago
JGBs Fall Amid Concerns Over Japan's Fiscal Policies
JGBs fell in price terms in early Tokyo trade amid concerns over Japan's fiscal policies.
JGBs Fall Amid Concerns Over Japan's Fiscal Policies
Negative
WSJ
15 days ago
Nikkei Falls 1.0%, Dragged by Electronics, Tech Stocks
Japanese stocks were lower in early trade as uncertainty over the Middle East conflict continues.
Nikkei Falls 1.0%, Dragged by Electronics, Tech Stocks
Neutral
WSJ
18 days ago
Newest Bank of Japan Policymaker Pledges to Keep Careful Eye on Yen
Ayano Sato pledged to carefully watch the impact of a weak yen on prices, though she didn't give any clear hints on her monetary policy stance.
Newest Bank of Japan Policymaker Pledges to Keep Careful Eye on Yen
Positive
Market Watch
22 days ago
Japanese stocks are on fire. Here's what's driving the hot streak.
Japanese equities have hit all-time highs at a pace not seen since 1989.
Japanese stocks are on fire. Here's what's driving the hot streak.
Neutral
Barrons
22 days ago
Japan Is an Investing Giant for Mom and Pop. It Just Needs to Convince Them.
A shift in Japan's large pool of household financial assets could reshape capital markets, one analyst says.
Japan Is an Investing Giant for Mom and Pop. It Just Needs to Convince Them.
Neutral
Business Wire
26 days ago
GondolaBio Announces Positive Phase 2a Results Demonstrating 79% Plasma Protoporphyrin IX Reduction and Disease-Modifying Potential of PORT-77 for Erythropoietic Protoporphyria
PALO ALTO, Calif.--(BUSINESS WIRE)--GondolaBio, a clinical-stage biopharmaceutical company developing novel medicines for patients living with genetic diseases, on behalf of its affiliate Portal Therapeutics, today announced positive data from its Phase 2a GATEWAY trial of PORT-77 in patients with erythropoietic protoporphyria (EPP). PORT-77 is a novel investigational oral, small molecule ABCG2 inhibitor designed to treat EPP and X-linked protoporphyria (XLP), two rare genetic disorders charact.
GondolaBio Announces Positive Phase 2a Results Demonstrating 79% Plasma Protoporphyrin IX Reduction and Disease-Modifying Potential of PORT-77 for Erythropoietic Protoporphyria
Negative
CNBC
29 days ago
Why Japan's $70 billion-plus intervention and a rate hike didn't prop up the yen more
Japan spent about $73 billion on foreign exchange intervention and the Bank of Japan has raised rates, but the yen remains near 160 against the dollar. A wide U.S.-Japan rate gap, carry trades and Prime Minister Sanae Takaichi's reflationary stance continue to weigh on the currency.
Why Japan's $70 billion-plus intervention and a rate hike didn't prop up the yen more
Neutral
WSJ
29 days ago
Japan's Consumer Inflation Held Steady in May
Consumer inflation remained steady last month, with economists noting that the full effect of higher oil prices has yet to emerge.
Japan's Consumer Inflation Held Steady in May
Neutral
CNBC
29 days ago
Japan core inflation holds steady in May, matching expectations despite energy price concerns
Japan core inflation holds steady in May, matching expectations despite energy price concerns
Japan core inflation holds steady in May, matching expectations despite energy price concerns
Neutral
WSJ
1 month ago
Bank of Japan Could Raise Rates Even If Mideast Uncertainty Persists
Japan's central bank could look past Middle East uncertainty and raise interest rates if inflation becomes a bigger threat to the economy than the risk of slowing growth, Gov. Kazuo Ueda said.
Bank of Japan Could Raise Rates Even If Mideast Uncertainty Persists